Literature DB >> 29204955

The "Gut Feeling": Breaking Down the Role of Gut Microbiome in Multiple Sclerosis.

Samantha N Freedman1,2, Shailesh K Shahi2, Ashutosh K Mangalam3,4.   

Abstract

Multiple sclerosis (MS) is a chronic neuroinflammatory disease of the central nervous system with unknown etiology. Recently, the gut microbiota has emerged as a potential factor in the development of MS, with a number of studies having shown that patients with MS exhibit gut dysbiosis. The gut microbiota helps the host remain healthy by regulating various functions, including food metabolism, energy homeostasis, maintenance of the intestinal barrier, inhibition of colonization by pathogenic organisms, and shaping of both mucosal and systemic immune responses. Alteration of the gut microbiota, and subsequent changes in its metabolic network that perturb this homeostasis, may lead to intestinal and systemic disorders such as MS. Here we discuss the findings of recent MS microbiome studies and potential mechanisms through which gut microbiota can predispose to, or protect against, MS. These findings highlight the need of an improved understanding of the interactions between the microbiota and host for developing therapies based on gut commensals with which to treat MS.

Entities:  

Keywords:  Multiple sclerosis (MS); experimental autoimmune encephalomyelitis (EAE); gut microbiome; host–microbe interaction; immune response; microbial metabolism

Mesh:

Substances:

Year:  2018        PMID: 29204955      PMCID: PMC5794701          DOI: 10.1007/s13311-017-0588-x

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  214 in total

1.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells.

Authors:  Yukihiro Furusawa; Yuuki Obata; Shinji Fukuda; Takaho A Endo; Gaku Nakato; Daisuke Takahashi; Yumiko Nakanishi; Chikako Uetake; Keiko Kato; Tamotsu Kato; Masumi Takahashi; Noriko N Fukuda; Shinnosuke Murakami; Eiji Miyauchi; Shingo Hino; Koji Atarashi; Satoshi Onawa; Yumiko Fujimura; Trevor Lockett; Julie M Clarke; David L Topping; Masaru Tomita; Shohei Hori; Osamu Ohara; Tatsuya Morita; Haruhiko Koseki; Jun Kikuchi; Kenya Honda; Koji Hase; Hiroshi Ohno
Journal:  Nature       Date:  2013-11-13       Impact factor: 49.962

2.  Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity.

Authors:  Melanie Schirmer; Sanne P Smeekens; Hera Vlamakis; Martin Jaeger; Marije Oosting; Eric A Franzosa; Rob Ter Horst; Trees Jansen; Liesbeth Jacobs; Marc Jan Bonder; Alexander Kurilshikov; Jingyuan Fu; Leo A B Joosten; Alexandra Zhernakova; Curtis Huttenhower; Cisca Wijmenga; Mihai G Netea; Ramnik J Xavier
Journal:  Cell       Date:  2016-12-15       Impact factor: 41.582

3.  Anti-inflammatory effect of gamma-irradiated genistein through inhibition of NF-κB and MAPK signaling pathway in lipopolysaccharide-induced macrophages.

Authors:  Eui-Baek Byun; Nak-Yun Sung; Mi-So Yang; Byung-Soo Lee; Du-Sup Song; Jan-Nam Park; Jae-Hun Kim; Beom-Su Jang; Dae-Seong Choi; Sang-Hyun Park; Young-Beob Yu; Eui-Hong Byun
Journal:  Food Chem Toxicol       Date:  2014-12       Impact factor: 6.023

4.  Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease.

Authors:  Ashutosh Mangalam; Shailesh K Shahi; David Luckey; Melissa Karau; Eric Marietta; Ningling Luo; Rok Seon Choung; Josephine Ju; Ramakrishna Sompallae; Katherine Gibson-Corley; Robin Patel; Moses Rodriguez; Chella David; Veena Taneja; Joseph Murray
Journal:  Cell Rep       Date:  2017-08-08       Impact factor: 9.423

5.  Human genetics shape the gut microbiome.

Authors:  Julia K Goodrich; Jillian L Waters; Angela C Poole; Jessica L Sutter; Omry Koren; Ran Blekhman; Michelle Beaumont; William Van Treuren; Rob Knight; Jordana T Bell; Timothy D Spector; Andrew G Clark; Ruth E Ley
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

6.  Gut microbiota in multiple sclerosis: possible influence of immunomodulators.

Authors:  Brandi L Cantarel; Emmanuelle Waubant; Christel Chehoud; Justin Kuczynski; Todd Z DeSantis; Janet Warrington; Arun Venkatesan; Claire M Fraser; Ellen M Mowry
Journal:  J Investig Med       Date:  2015-06       Impact factor: 2.895

7.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

8.  Fecal microbiota in early rheumatoid arthritis.

Authors:  Jussi Vaahtovuo; Eveliina Munukka; Mika Korkeamäki; Reijo Luukkainen; Paavo Toivanen
Journal:  J Rheumatol       Date:  2008-06-01       Impact factor: 4.666

9.  Gut microbiota composition and relapse risk in pediatric MS: A pilot study.

Authors:  Helen Tremlett; Douglas W Fadrosh; Ali A Faruqi; Janace Hart; Shelly Roalstad; Jennifer Graves; Susan Lynch; Emmanuelle Waubant
Journal:  J Neurol Sci       Date:  2016-02-20       Impact factor: 3.181

10.  Bile signalling promotes chronic respiratory infections and antibiotic tolerance.

Authors:  F Jerry Reen; Stephanie Flynn; David F Woods; Niall Dunphy; Muireann Ní Chróinín; David Mullane; Stephen Stick; Claire Adams; Fergal O'Gara
Journal:  Sci Rep       Date:  2016-07-19       Impact factor: 4.379

View more
  48 in total

1.  The Microbiome and Neurologic Disease: Past and Future of a 2-Way Interaction.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

2.  Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells.

Authors:  Hilary A Seifert; Gil Benedek; Ha Nguyen; Grant Gerstner; Ying Zhang; Gail Kent; Arthur A Vandenbark; Jürgen Bernhagen; Halina Offner
Journal:  Metab Brain Dis       Date:  2018-06-18       Impact factor: 3.584

Review 3.  The role of short-chain fatty acids in central nervous system diseases.

Authors:  Yin Dong; Chun Cui
Journal:  Mol Cell Biochem       Date:  2022-05-21       Impact factor: 3.396

Review 4.  Gastrointestinal Dysfunction in Parkinson's Disease.

Authors:  Delaram Safarpour; Kaveh Sharzehi; Ronald F Pfeiffer
Journal:  Drugs       Date:  2022-01-25       Impact factor: 9.546

5.  Diet quality and risk of multiple sclerosis in two cohorts of US women.

Authors:  Dalia L Rotstein; Marianna Cortese; Teresa T Fung; Tanuja Chitnis; Alberto Ascherio; Kassandra L Munger
Journal:  Mult Scler       Date:  2018-10-23       Impact factor: 6.312

6.  Interactions between host genetics and gut microbiota determine susceptibility to CNS autoimmunity.

Authors:  Theresa L Montgomery; Axel Künstner; Josephine J Kennedy; Qian Fang; Lori Asarian; Rachel Culp-Hill; Angelo D'Alessandro; Cory Teuscher; Hauke Busch; Dimitry N Krementsov
Journal:  Proc Natl Acad Sci U S A       Date:  2020-10-19       Impact factor: 11.205

7.  Go-sha-jinki-Gan Alleviates Inflammation in Neurological Disorders via p38-TNF Signaling in the Central Nervous System.

Authors:  Shiying Jiang; Kousuke Baba; Keisuke Hagihara; Hideki Mochizuki; Tatsusada Okuno; Makoto Kinoshita; Chi-Jing Choong; Hideki Hayakawa; Hiroshi Sakiyama; Kensuke Ikenaka; Seiichi Nagano; Tsutomu Sasaki; Munehisa Shimamura; Yoshitaka Nagai
Journal:  Neurotherapeutics       Date:  2020-10-20       Impact factor: 7.620

Review 8.  Nutritional and ecological perspectives of the interrelationships between diet and the gut microbiome in multiple sclerosis: Insights from marmosets.

Authors:  Maria Elisa Perez-Muñoz; Scott Sugden; Hermie J M Harmsen; Bert A 't Hart; Jon D Laman; Jens Walter
Journal:  iScience       Date:  2021-06-10

9.  The impact of device-assisted therapies on the gut microbiome in Parkinson's disease.

Authors:  Michal Lubomski; Xiangnan Xu; Jean Y H Yang; Carolyn M Sue; Ryan L Davis; Andrew J Holmes
Journal:  J Neurol       Date:  2021-06-15       Impact factor: 6.682

10.  Isoflavone diet ameliorates experimental autoimmune encephalomyelitis through modulation of gut bacteria depleted in patients with multiple sclerosis.

Authors:  Samantha N Jensen; Nicole M Cady; Shailesh K Shahi; Stephanie R Peterson; Arnav Gupta; Katherine N Gibson-Corley; Ashutosh K Mangalam
Journal:  Sci Adv       Date:  2021-07-09       Impact factor: 14.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.